GCM
RPRX icon

Graham Capital Management’s Royalty Pharma RPRX Stock Holding History

Graham Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,847
Closed -$249K – 1286
2023
Q4 		$249K Sell
8,847
-19,965
-69% -$549K 0.01% 781
2023
Q3 		$782K Sell
28,812
-82,994
-74% -$2.46M 0.02% 430
2023
Q2 		$3.44M Buy
111,806
+96,014
+608% +$3.25M 0.12% 137
2023
Q1 		$569K Sell
15,792
-55,279
-78% -$2.05M 0.02% 708
2022
Q4 		$2.81M Buy
71,071
+54,917
+340% +$2.29M 0.11% 165
2022
Q3 		$649K Buy
+16,154
New +$690K 0.03% 656
2022
Q2 		– Sell
-44,459
Closed -$1.73M – 1217
2022
Q1 		$1.73M Buy
44,459
+39,142
+736% +$1.54M 0.08% 160
2021
Q4 		$211K Buy
+5,317
New +$207K 0.01% 449

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return